A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5375 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2321157
This patent application describes the treatment of Addictive disorders, Psychoactive Substance Use disorders, Intoxication disorders, Inhalation disorders, Alcohol addiction, Tobacco addiction and or Nicotine addiction; and Attention Deficit Hyperactivity Disorder (ADHD); comprising administering a therapeutically effective, nontoxic dose of Reboxetine and derivatives and or pharmaceutically acceptable salts thereof to a patient.
La présente invention concerne le traitement de troubles de la toxicomanie, de troubles liés à l'utilisation de substances psychotropes, de troubles liés à l'intoxication, de troubles liés à l'inhalation, de l'alcoolisme, du tabagisme et de la dépendance à la nicotine ainsi que de troubles de l'hyperactivité avec déficit d'attention. Ce traitement consiste à administrer au patient une dose thérapeutiquement efficace, non toxique, de reboxetine et de ses dérivés et/ou de sels pharmaceutiquement acceptables de ces composés.
Hassan Fred
Mccall John Michael
Taylor Duncan Paul
von Voigtlander Philip F.
Wong Erik Ho Fong
Macrae & Co.
Pharmacia & Upjohn Company
LandOfFree
New treatments for nervous disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New treatments for nervous disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New treatments for nervous disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1498206